Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Antibody Abstract

amino acid sequence displays high conservation with the rabbit homolog. antibodies-online currently ships , and Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Kits (11) to destinations worldwide.

list all antibodies Gene Name GeneID UniProt
MYLPF 17907 P97457
MYLPF 29895 Q96A32
MYLPF 24584 P04466

Show Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Antigene Profile

How to order from antibodies-online
  • +1 404 474 4654
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Antibodies at antibodies-online.com

Showing 10 out of 25 Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Antibodies

ABIN Reactivity Host Conjugate Application Images Quantity Delivery Price Details
ABIN362766 Human Rabbit Un-conjugated WB, IF   50 µL 2 to 3 Days
165.00 $
Details
ABIN362085 Human Rabbit Un-conjugated IHC   50 µL 2 to 3 Days
198.00 $
Details
ABIN1544608 Human Rabbit Un-conjugated WB 50 µg 2 to 3 Days
289.00 $
Details
ABIN273984 Human Rabbit Un-conjugated WB 50 µg 8 to 9 Days
155.22 $
Details
ABIN650101 Human Rabbit Un-conjugated WB, IHC   100 µL 2 to 3 Days
450.00 $
Details
ABIN966635 Human Rabbit Un-conjugated IHC   100 µg 5 to 7 Days
385.00 $
Details
ABIN558372 Human Rabbit Un-conjugated WB   0.1 mL 9 to 11 Days
319.44 $
Details
ABIN526143 Human Mouse Un-conjugated WB 100 µg 11 to 12 Days
394.24 $
Details
ABIN558814 Rabbit Mouse Un-conjugated ICC, IF, IHC (fro), IHC (p), WB   0.25 mL 9 to 11 Days
406.56 $
Details
ABIN349093 Human Rabbit Un-conjugated IHC, WB   50 µg 8 to 9 Days
210.22 $
Details

MYLPF Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality
Mouse (Murine) , , ,


Human , , ,
,
,
Rat (Rattus) , , ,

,

Top referenced Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Antibodies

  1. ABIN650101 : Sweeney: Function of the N terminus of the myosin essential light chain of vertebrate striated muscle. in Biophysical journal 1995 (PubMed)
    Show all 4 references for ABIN650101

  2. ABIN362085 : Janiak, Zemskov, Belkin: Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. in Molecular biology of the cell 2006 (PubMed)
    Show all 3 references for ABIN362085

  3. ABIN362766 : Rameh, Armelin: Downregulation of JE and KC genes by glucocorticoids does not prevent the G0----G1 transition in BALB/3T3 cells. in Molecular and cellular biology 1992 (PubMed)
    Show all 3 references for ABIN362766

More Antibodies against Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Interaction Partners

Mouse (Murine) Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) interaction partners

  1. Results indicated that sine oculis homeobox (show PRRX1 Antibodies) 1 (Six1 (show SIX1 Antibodies)) overexpression could significantly promote the expression of fast-type muscle genes Atp2a1 (show ATP2A1 Antibodies), Srl, and Mylpf.

  2. Therefore, we suggest that Chr 21 gene(s) distal from the ETS2 (show ETS2 Antibodies) locus reduce mouse mlc2a and PEBP (show PEBP1 Antibodies) expression in DS model mice and DS.

  3. RLC-f is necessary for skeletal muscle formation. The lack of skeletal muscle formation observed in RLC-f null mice indicates the total dependence of skeletal muscle development on the presence of RLC-f during embryogenesis.

  4. Data suggest that the overexpression of fast skeletal muscle myosin light chain in murine asthma may be associated with the changes of bronchial smooth muscle.

Human Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) interaction partners

  1. Results suggest that Aurora B (show AURKB Antibodies), but not Rho/MLCK (myosin-light-chain kinase (show MYLK Antibodies)) signaling, is essential for the localization of 2P-MRLC (myosin regulatory light chains) to the midzone in dividing HeLa cells.

  2. an interplay between phosphorylation and glycosylation of MLC2 (show MYL9 Antibodies), which might be involved in the development of muscle atrophy and associated changes

  3. Newly implicated variants (MYL2 (show MYL2 Antibodies), C12orf51 and OAS1 (show OAS1 Antibodies)) were found to be significantly associated with 1-h plasma glucose as predisposing risk factors for type 2 diabetes.

  4. study concludes the mutations in the last exon of MYL2 are responsible for a novel autosomal recessive lethal myosinopathy due to defects changing the C-terminal tail of the ventricular form of the myosin regulatory light chain

  5. NDRG1 (show NDRG1 Antibodies) inhibited an important regulatory pathway mediated by ROCK1 (show ROCK1 Antibodies)/pMLC2 pathway that modulates stress fiber assembly.

  6. AMPK mediates spindle pole-associated pMRLC(ser19) to control spindle orientation via regulation of actin cortex-astral microtubule attachments

  7. MLC2 (show MYL9 Antibodies) isoforms localisation is dependent on cell cycle in HeLa cells.

  8. results suggest that the A13T mutation triggers a hypertrophic response through changes in cardiac sarcomere organization and myosin cross-bridge function leading to abnormal remodelling of the heart.

  9. These data demonstrate that smMLCK is a specific and efficient kinase for the in vitro phosphorylation of MYL2, cardiac, and smooth muscle myosin.

  10. This is the first report of mutations in TPM1 (show TPM1 Antibodies), MY L3, and MYL2 (show MYL2 Antibodies) associated with primary, non-hypertrophied restrictive cardiomyopathy.

Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Antigen Profile

Gene names and symbols associated with MYLPF

myosin light chain, phosphorylatable, fast skeletal muscle (mylpf) , myosin light chain, phosphorylatable, fast skeletal muscle (MYLPF) , myosin light chain 2 type 2 (LOC100009542) , myosin light chain, phosphorylatable, fast skeletal muscle (Mylpf) , myosin, light chain 2, regulatory, cardiac, slow (MYL2)

SkMLC , MYLPF , 2410014J02Rik , MLC-2 , Mlc2 , HUMMLC2B , MRLC2 , MYL11 , MLC2 , Myl2 , Myolc1 , DTNB , G2 , LC2f , CMH10

Protein level used designations for MYLPF

myosin light chain, phosphorylatable, fast skeletal muscle , myosin light chain 2 , myosin regulatory light chain 2, skeletal muscle isoform type 2 , G2 , DTNB , MLC-2 , fast skeletal myosin light chain 2 , Myosin regulatory light chain 2, skeletal muscle isoform type 1 , myosin regulatory light chain 2, skeletal muscle isoform , MLC2F , MLC2B , myosin, light chain 11, regulatory , Myosin light polypeptide 2 alkali , Myosin, light polypeptide 2, alkali , Myosin, light polypeptide 2, alkali; ventricular, skeletal, slow , ventricular skeletal slow , ventricular, skeletal, slow , myosin light chain type 2 , skeletal muscle isoform , MLC-2v , RLC of myosin , cardiac ventricular myosin light chain 2 , myosin regulatory light chain 2, ventricular/cardiac muscle isoform , myosin, light polypeptide 2, regulatory, cardiac, slow , regulatory light chain of myosin , slow cardiac myosin regulatory light chain 2

Antigen Summary

Thus gene encodes the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy.

GENE ID SPECIES
399251 Xenopus laevis
454042 Pan troglodytes
479772 Canis lupus familiaris
100009542 Oryctolagus cuniculus
100270715 Ovis aries
17907 Mus musculus
29895 Homo sapiens
514106 Bos taurus
24584 Rattus norvegicus
776775 Gallus gallus
4633 Homo sapiens
Selected quality suppliers for Myosin Light Chain, phosphorylatable, Fast Skeletal Muscle (MYLPF) Antibodies
Did you look for something else?
back to top